Blue Horseshoe Stocks: The Week in Review

Looking Back on a Stellar Week

We couldn’t have asked for a better week of winning picks, especially coming off of a holiday weekend, so to wrap things up we’re going to go over all of our successful picks, and what kinds of moves they made.

GEI Global Energy Corp. GEIG

Of course the big winner for this week was GEIG, and in fact was one of our most successful picks in quite some time. We initiated coverage of GEIG on Wednesday, the stock opened up and saw a low of .0098 very briefly before exploding to a high of .08, a single-session move of 716% While it’s unlikely that traders could have picked up any of those sub-penny shares, the real action began around .015, still leaving the opportunity at a high number, with gains of up to 433% being very possible. The stock traded record volume.

Camtek, Ltd. CAMT

CAMT came off of Monday’s extended watchlist to perform exceptionally well for us, running from a low of 3.42 to 5.14, a solid 50% gainer on more than 40x its 3-month average volume.

GW Pharmaceuticals, Inc. GWPH

On Tuesday, we were talking about GWPH, stating: “Once we see a solid level of support established and GWPH begins to rebound, then we’ll be able to adjust our options-trading strategies accordingly.” Sure enough, the stock did indeed find solid support at 85.32. We would subsequently see an uptrend carry GWPH as high as 93.97. As a result, the $85 Weekly Calls traded in an impressive range from 4.30 to 9.60, a total possible gain of 123% while the $90 Calls made an even more impressive move. They would run from 1.55-5.69, giving traders a chance at profits up to 267% We’ll continue to watch those weekly contracts today for a possible intraday flip opportunity.

American Apparel, Inc. APP

This spring, we started reminding people that as the retail season approaches, APP is a stock that we traditionally play for nice gains every year. 2014 has proven no different. We saw a low of .51
out of APP on June 24th, and the stock has made more than a 100% move up, touching 1.05 during yesterday’s session. The retail season has yet to even kick into gear, and already we’ve been able to reap some excellent rewards from this retail stock; it will certainly remain on our watchlist as the summer begins to wind down.

Inception Mining, Inc. IMII

We first added IMII to our lists yesterday as a long term-mining play. We wanted the stock to hold support off of the 200DMA, and break resistance at the 50DMA, and that’s just what we got. The stock has made higher lows and higher highs over the past couple of sessions, so it appears we’re off to a great start with this one. On the chart, the RSI cracked above the 50-line, and the MACD is still heading for a bullish cross, so we’re still very interested to see what this play could do in the days and weeks ahead.


Extended Watchlist:
HALO, DGLY, JOEZ, EVRY, PBR

SFAZ, Options Trading & Extended Watchlist

Options Trading
We dabble in options trading from time to time, and want to remind our readers that this is not for the faint of heart. These ideas are meant for day-trading opportunities, and we can’t stress enough that it should be considered very high risk. That being said, we’d still like to share our current thoughts on the subject.

It appears as if the markets want to open up with an uptrend today. We’ve seen the biggest losses of the year for the past two days running. While uncertain as to whether that pullback to continue, at least from where we stand now, it appears that the markets want to rebound. In the event of an overall uptrend today, we are going to be focusing specifically on the weekly SPY Calls, and VXX Puts.

On the flip-side, if we continue to see more of this recent sell-off, we will obviously be reversing our strategy to focus mainly on the SPY Puts, and VXX Calls, as the two indices tend to move inversely to one another. At any rate, we want to stay close to the money, and have our strike price be pushed in the money. For example, the SPY is currently trading at 151.32 pre-market, so we are currently looking at the 151.00 Weekly SPY Calls.
___

Safe Technologies International, Inc. SFAZ

We first alerted SFAZ via our extended watchlist on January 4th. On that day, we saw the stock run from .008 up .014, for a one day pop of 75%

After mostly trading sideways since that initial run, the stock has now found a solid level of support at .002. Chart conditions are beginning to come across as favorable once again, as we’ve pointed out below.

Accumulation & Distribution have been on a steady rise, even as the stock has been feeling out a bottom. The RSI continues to hold above the 50MA overlay and looks like it’s beginning to push the 50-line. We appear to be at a pivot point with regard to resistance, the 50 and 20DMA’s at .0026, and .0028, respectively. Meanwhile, the blue bars on the MACD histogram are about to flip up topside as we are about to see a bullish cross, and the Slow STO recently passed above the 50MA overlay.


___

Extended Watchlist:
MCET, PDGO, BRCI, SNDY, JOEZ, MRVL 

BMSN, CERP, COIN & Extended Watchlist

Bio-Matrix Scientific Group, Inc. BMSN

BMSN is a really good example of why we suggest that our readers keep a working watchlist of all of the stocks we mention, as there are instances when one of our more dated interests crops up with a new development that sends the stock on a ride. Such was the case with BMSN yesterday, as the company released a PR iterating the initiation of clinical trials for the company’s anemia treatment, HemaXellerate. As a result, yesterday’s trading carried the stock as high as .0062.

A week ago today, we mentioned that we’d like to see support hold at .0035 and .0021 to remain bullish on BMSN, which it did, in fact, manage. From the low of .0032 since last Wednesday’s mention, we are up 94% – From the low following our first ever alert (.0003 on Dec. 26th), yesterday’s high represented an unbelievably impressive gain of 1967%

Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia

Clinical Trial to Evaluate “First in Class” Approach to Bone Marrow Failure Diseases

SAN DIEGO, CA, Feb 05, 2013 (MARKETWIRE via COMTEX) — Regen BioPharma a wholly-owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today filing of an Investigational New Drug (IND) application with the FDA to initiate clinical trials assessing the company’s HemaXellerate I(TM) stem cell drug in patients with drug-refractory aplastic anemia.
___

Cereplast, Inc. CERP

We first mentioned CERP as a feature on January 24th, at which time we saw a low of .023. On the 25th, it spiked 59% to .0365. This past Friday the stock saw another low of .0182, before running yesterday to a new high at .043, for an added gain of 136%, and bringing our total cumulative gains to 195% in just under two weeks’ time.

With the amount of momentum and volume we’ve seen trade through CERP recently, we definitely want to keep this one high on our watchlists.

Cereplast Provides Shareholder Update on Italian Application Decree & Announces $300,000 in New Revenue

EL SEGUNDO, Calif., Feb 05, 2013 (GLOBE NEWSWIRE via COMTEX) — Cereplast, Inc. (OTCQB:CERP) (the “Company”), a leading manufacturer of proprietary biobased, compostable and sustainable bioplastics, generated approximately $300,000 in new revenue during the last two weeks of January 2013. These orders received are in addition to the $500,000 of new revenue that was announced on January 23, 2013.

___

Converted Organics, Inc. COIN

 COIN appeared on our extended watchlist yesterday, and thus posted a sizable gain, running from .0019-0029, only to close the day at .0025. That gave us a quick chance at up to 53% in intraday gains.
___

As most of you are undoubtedly aware, we first began really zeroing in on cannabis stocks back in October. From our continued reports on the subject this week, we have seen even more gains to add to the already monumental profits that these plays have afforded us. Our running tally of tracked pot stocks totaled 10 at the start of this week. We are all but certain that even more will crop up (no pun intended), as the fervor over this newly expanding market sector continues to intensify.
___

Extended Watchlist:
SFOR, SCXN, CCRY, JOEZ, CNAM, CLSN